Dr. Barry Arkles has been appointed the Chief Executive Officer of Gelest Inc. effective 12 October 2020. Barry Arkles is also the Chairman of the Board of Gelest, the company he co-founded in 1991. On 1 October 2020 Gelest was acquired by Mitsubishi Chemical America (MCA), Inc., the U.S. subsidiary of Mitsubishi Chemical Corporation. Barry Arkles’ appointment follows the resignation of Ken Gayer as CEO of Gelest.
Barry Arkles formed Gelest Inc. to develop and manufacture silicon and metal-organic based chemicals and polymers for applications in microelectronics, optoelectronics, medical devices and pharmaceuticals. Prior to the founding of Gelest, Inc., he was a co-founder of Petrarch Systems, Inc. and then Vice-Preseident of Corporate Development for Huls America. He received his doctorate from Temple University and has published over 150 technical articles and been awarded over 75 patents.
“Dr. Arkles’ comprehensive knowledge of the business and technology of Gelest provides excellent continuity as members of the talented leadership team join to support the continued growth of the company in the key markets served: medical device, semiconductor, personal care, pharmaceutical and diagnostic science,” remarked Steve Yurich, President of MCA.
Barry Arkles stated: “My primary objective will be to deploy the technological strengths of Gelest and its parent Mitsubishi Chemical in service to the customer base that depends on us and the communities that we serve. With the support of our reliable and talented employees, I anticipate a smooth transition into the Mitsubishi Chemical organization while sustaining the continued growth of Gelest.”